Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BMMC in Acute Ischemic Stroke
NCT01501773Phase 2Completed
- Sponsor
- Manipal Acunova
- Start
- Oct 2008
- Primary completion
- Oct 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in ischemic stroke, sponsored by Manipal Acunova. Started Oct 2008; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01501773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01501773.